Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

European Urology

Volumn 39, Issue SUPPL. 4, 2001, Pages 33-34

  Hugosson, Jonas ^a   Lilja, Hans ^b   Lodding, Pär ^a   Pihl, Carl Gustav ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER GROWTH; CANCER SCREENING; CONFERENCE PAPER; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SWEDEN; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

EID: 0035012442     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052582     Document Type: Conference Paper

References (3)